On Monday, Cantor Fitzgerald issued an industry report on the infrastructure and AI software sector, which has experienced a challenging period. The Software (ETR:SOWGn) ETF (IGV) recorded its fourth ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Cartesian Therapeutics (NASDAQ:RNAC), currently trading at $15.80, with a steady price target of $22.00. The stock has experienced an ...

Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will post earnings per share of ($2.03) for the year, up from their previous forecast of ($2.20). Cantor Fitzgerald currently ...

Exagen Inc. (NASDAQ:XGN – Free Report) – Equities researchers at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Exagen in a research note issued on Wednesday ...

The financial services giant Cantor Fitzgerald is predicting the stock market will see rallies in the next one to two weeks. In a new interview on CNBC Television, Eric Johnston, a macro strategist at ...

On Thursday, shares of 3D Systems (NYSE:DDD) and Proto Labs (NYSE:PRLB) maintained their Overweight ratings, as per a recent industry report by Cantor Fitzgerald on the industrial technology sector.

Morgan Stanley Institutional Fund, Inc. Global Infrastructure Portfolio Class IR 18.42 Goldman Sachs Global Infrastructure Fund Institutional Class 18.45 Goldman Sachs Global Infrastructure Fund ...